IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation
Crossref DOI link: https://doi.org/10.1038/cmi.2014.58
Published Online: 2014-08-04
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deng, Xiao-Mei
Yan, Shang-Xue
Wei, Wei
Text and Data Mining valid from 2014-08-04
Version of Record valid from 2014-08-04
Article History
Received: 12 January 2014
Revised: 13 June 2014
Accepted: 14 June 2014
First Online: 4 August 2014
Competing interests
: The authors declare that there are no conflicts of interest.